Inventor · Paris, FR

Pierre Charneau

35Patents
8h-index
48Co-inventors
75Inventor score

Filing activity: Jul 11, 1997 → Feb 19, 2020

Most-cited inventions

PatentTitleAreaCited byStatus
US6682907B1 Use of triplex structure DNA in transferring nucleotide sequences Chemistry; Metallurgy 89 Expired
US6103462A Rapid single-cycle assay for human immunodeficiency virus type-1 drug resistance Chemistry; Metallurgy 16 Expired
US8343718B2 Strain of SARS-associated coronavirus and applications thereof Physics 15 Active
US7968332B2 Lentiviral vectors for the preparation of immunotherapeutical compositions Chemistry; Metallurgy 12 Active
US8093042B2 Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA Chemistry; Metallurgy 12 Active
US7736850B2 Strain of SARS-associated coronavirus and applications thereof Physics 11 Active
US8586364B2 Cells and methodology to generate non-segmented negative-strand RNA viruses Chemistry; Metallurgy 10 Active
US7981671B2 Use of triplex structure DNA in transferring nucleotide sequences Chemistry; Metallurgy 10 Active
US8420104B2 Lentiviral gene transfer vectors and their medicinal applications Emerging Cross-Sectional Technologies 8 Active
US6399294B1 Nucleotide sequences of HIV-1 type (or subtype) O retrovirus antigens Emerging Cross-Sectional Technologies 8 Expired
US8349606B2 Lentiviral vectors for the preparation of immunotherapeutical compositions Chemistry; Metallurgy 7 Active
US10407695B2 Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA Chemistry; Metallurgy 7 Active
US7157225B2 Nucleotide sequences of HIV-1 type (or subtype) O retrovirus antigens Emerging Cross-Sectional Technologies 5 Expired
US8367068B2 Use of triplex structure DNA in transferring nucleotide sequences Chemistry; Metallurgy 5 Active
US8460678B2 Use of triplex structure DNA in transferring nucleotide sequences Chemistry; Metallurgy 4 Active
US8450087B2 Use of triplex structure DNA in transferring nucleotide sequences Chemistry; Metallurgy 4 Active
US8652807B2 Lentiviral vectors for the preparation of immunotherapeutical compositions Chemistry; Metallurgy 3 Active
US8512993B2 Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA Chemistry; Metallurgy 3 Active
US9238824B2 Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA Chemistry; Metallurgy 2 Active
US8512994B2 Lentiviral triplex DNA, and vectors and recombinant cells containing lentiviral triplex DNA Chemistry; Metallurgy 2 Active
US8236324B2 Nucleotide sequences of HIV-1 group (or subgroup) O retroviral antigens Emerging Cross-Sectional Technologies 2 Active
US9442114B2 Isolated and purified strains of Chikungunya virus and polynucleotides and polypeptides sequences, diagnostic and immunogenical uses thereof Emerging Cross-Sectional Technologies 2 Active
US9328146B2 Lentiviral gene transfer vectors and their medicinal applications Emerging Cross-Sectional Technologies 1 Active
US8158413B2 Lentiviral vector-based vaccine Emerging Cross-Sectional Technologies 1 Active
US8222029B2 Lentiviral vector-based vaccine Emerging Cross-Sectional Technologies 1 Active

Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.